| MRUS Stock | | | USD 47.00 0.61 1.31% |
EVP
Peter JD is Company EVP of Merus BV
| Age | 47 |
| Address | Uppsalalaan 17, Utrecht, Netherlands, 3584 CT |
| Phone | 31 30 253 8800 |
| Web | https://www.merus.nl |
Merus BV Management Efficiency
The company has return on total asset
(ROA) of
(0.2747) % which means that it has lost $0.2747 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity
(ROE) of
(0.4288) %, meaning that it created substantial loss on money invested by shareholders. Merus BV's management efficiency ratios could be used to measure how well Merus BV manages its routine affairs as well as how well it operates its assets and liabilities.
Return On Tangible Assets is likely to drop to -0.29 in 2025.
Return On Capital Employed is likely to gain to -0.34 in 2025. At this time, Merus BV's
Total Assets are comparatively stable compared to the past year.
Non Current Assets Total is likely to gain to about 224.3
M in 2025, despite the fact that
Other Assets are likely to grow to (511.8
M).
Merus BV currently holds 9.91
M in liabilities with Debt to Equity
(D/E) ratio of 0.04, which may suggest the company is not taking enough advantage from borrowing. Merus BV has a current ratio of 6.49, suggesting that it is
liquid enough and is able to pay its financial obligations when due. Note, when we think about Merus BV's use of debt, we should always consider it together with its cash and equity.
Similar Executives
Merus N.V., a clinical-stage immuno-oncology company, engages in the discovery and development of bispecific antibody therapeutics in the Netherlands. The company was incorporated in 2003 and is headquartered in Utrecht, the Netherlands. Merus NV is traded on NASDAQ Exchange in the United States. Merus BV (MRUS) is traded on NASDAQ Exchange in USA. It is located in Uppsalalaan 17, Utrecht, Netherlands, 3584 CT and employs 260 people. Merus BV is listed under Biotechnology category by Fama And French industry classification.
Management Performance
Merus BV Leadership Team
Elected by the shareholders, the Merus BV's board of directors comprises two types of representatives: Merus BV inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Merus. The board's role is to monitor Merus BV's management team and ensure that shareholders' interests are well served. Merus BV's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Merus BV's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Ashley PharmD, Senior Affairs | |
| Kathleen Farren, IR Officer | |
| Gregory Perry, Chief Officer | |
| Hennie Hoogenboom, CoFounder Advisor | |
| Alexander Bakker, Chief VP | |
| Peter JD, Company EVP | |
| Cecilia Geuijen, Chief VP | |
| Jillian Connell, VP Communications | |
| Sven MD, President, CEO | |
| Cornelis Kruif, CTO VP | |
| Hui Liu, Chief Business Officer and Head of Merus U.S., Executive Vice President | |
| Harry Shuman, Chief Officer | |
| Andrew MD, Consultant | |
| Audrey Bergan, Chief Officer | |
| Shannon Campbell, Executive Officer | |
Merus Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Merus BV a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Additional Tools for Merus Stock Analysis
When running Merus BV's price analysis, check to
measure Merus BV's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Merus BV is operating at the current time. Most of Merus BV's value examination focuses on studying past and present price action to
predict the probability of Merus BV's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Merus BV's price. Additionally, you may evaluate how the addition of Merus BV to your portfolios can decrease your overall portfolio volatility.